Latest profit margin for Scancell Holdings plc: -639.1% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2026
Trailing 12 months ending Apr 2026
Scancell Holdings plc posts a profit margin of -639.1% as of April 2026. That compares with -337.6% in the prior-year period — down 89.3% year over year. That is below the Healthcare sector average of 17.63%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Scancell Holdings plc's profit margin was -337.6%. The latest reading is -639.1% — a 89.3% year-over-year decrease (period ending April 2026). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 17.63% is typical. Scancell Holdings plc's -639.1% is lower that level. That is roughly 3725.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Scancell Holdings plc's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -639.1% as of April 2026; use YoY and peer views to separate noise from signal.
Context for SCLP.L's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.63%), and (3) consistency with growth and profitability. This page covers the first two; Scancell Holdings plc's other metric pages and overview cover the third.